University of California San Francisco
Give to UCSF
Every fall, Matt Jacobson relives his Parkinson’s diagnosis so future pharmacists perceive the patient behind the prescription.
The study adds to a body of evidence indicating that pollution from cars, factories, power plants and forest fires joins established dementia risk factors like smoking and diabetes.
Researchers found that teens with migraines whose high schools started before 8:30 a.m. experienced close to three more headache days than those with later school start times.
An international research team led by UCSF scientists has shown, for the first time, that gut immune cells travel to the brain during multiple sclerosis flare-ups in patients.
Lisa had a rare mutation that meant she was not able to combine two words until she was 3, and she didn’t take part in imaginative play until she was 10. Could a drug for MS be repurposed to help her?
A cellular therapy for epilepsy developed at UCSF has been employed for the first time in a sea lion with intractable seizures caused by ingesting toxins from algal blooms.
The UCSF researchers — whose work spans investigations into autism spectrum disorder (ASD), oncology, and mitochondrial disease — were among 85 awardees for the grants that the NIH says “will fund highly innovative and unusually impactful biomedical or behavioral research proposed by extraordinarily creative scientists.”
Older adults who took weekly 15-minute “awe walks” for eight weeks reported increased positive emotions and less distress in their daily lives.
The achievement of “plug and play” performance demonstrates the value of so-called ECoG electrode arrays for BCI applications.
New UCSF research sheds light on how immune system B cells that infiltrate the central nervous system may drive multiple sclerosis.
UCSF scientists now have evidence from research that women with Alzheimer’s live longer than men with the disease because they have genetic protection from the ravages of the disease.
